Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ADUS NYSE:PACS NASDAQ:PGNY NASDAQ:TALK On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADUSAddus HomeCare$118.41+3.7%$111.97$88.96▼$136.72$2.10B0.8201,103 shs133,138 shsPACSPACS Group$12.02+2.4%$12.07$8.28▼$43.92$1.79B0.88435,974 shs612,141 shsPGNYProgyny$23.53+1.7%$22.55$13.39▼$26.76$1.99B1.321.14 million shs778,569 shsTALKTalkspace$2.80+2.9%$2.61$1.70▼$4.36$455.51M1.061.62 million shs1.20 million shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADUSAddus HomeCare-0.58%+0.28%+5.03%+1.80%-13.79%PACSPACS Group-1.93%+1.17%+1.58%+19.46%-70.78%PGNYProgyny+2.53%+2.57%+0.65%+12.72%+7.23%TALKTalkspace+5.84%+7.51%+4.62%-3.55%+52.81%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationADUSAddus HomeCare4.9404 of 5 stars3.53.00.05.03.82.53.1PACSPACS Group2.6734 of 5 stars3.41.00.00.01.40.01.9PGNYProgyny2.4656 of 5 stars2.42.00.00.03.52.51.3TALKTalkspace3.9551 of 5 stars3.53.00.00.03.23.31.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceADUSAddus HomeCare 3.00Buy$138.3816.86% UpsidePACSPACS Group 2.83Moderate Buy$33.33177.43% UpsidePGNYProgyny 2.73Moderate Buy$25.106.67% UpsideTALKTalkspace 3.00Buy$4.5060.71% UpsideCurrent Analyst Ratings BreakdownLatest TALK, ADUS, PGNY, and PACS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/22/2025ADUSAddus HomeCareRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$133.00 ➝ $134.008/20/2025PGNYProgynyCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$21.00 ➝ $23.008/19/2025ADUSAddus HomeCareBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetUnderweight ➝ Underweight$83.00 ➝ $109.008/8/2025PGNYProgynyRaymond James FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$28.008/8/2025PGNYProgynyCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$26.00 ➝ $28.008/6/2025ADUSAddus HomeCareTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$135.00 ➝ $139.007/17/2025PGNYProgynyTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$24.00 ➝ $27.007/16/2025ADUSAddus HomeCareJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$150.007/8/2025PGNYProgynyLeerink PartnrsSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Strong-Buy7/8/2025PGNYProgynyLeerink PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeMarket Perform ➝ Outperform$28.006/20/2025ADUSAddus HomeCareJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$150.00(Data available from 8/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookADUSAddus HomeCare$1.15B1.89$5.59 per share21.18$55.51 per share2.13PACSPACS Group$3.11B0.59N/AN/AN/A∞PGNYProgyny$1.17B1.73$0.35 per share67.03$5.99 per share3.93TALKTalkspace$187.59M2.50$0.01 per share228.93$0.67 per share4.18Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateADUSAddus HomeCare$73.60M$4.5326.1422.091.746.51%9.39%6.86%11/3/2025 (Estimated)PACSPACS Group$112.87MN/A0.006.75N/AN/AN/AN/A8/25/2025 (Estimated)PGNYProgyny$54.34M$0.5939.8836.201.894.28%10.69%7.12%N/ATALKTalkspace$1.15M$0.02140.0714.74N/A1.41%2.48%2.11%11/4/2025 (Estimated)Latest TALK, ADUS, PGNY, and PACS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/25/2025Q2 2025PACSPACS Group$0.45N/AN/AN/AN/AN/A8/7/2025Q2 2025PGNYProgyny$0.42$0.19-$0.23$0.19$315.70 million$332.87 million8/5/2025Q2 2025TALKTalkspace$0.01-$0.00-$0.01N/A$54.08 million$54.31 million8/4/2025Q2 2025ADUSAddus HomeCare$1.45$1.49+$0.04$1.20$345.71 million$349.44 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthADUSAddus HomeCareN/AN/AN/AN/AN/APACSPACS GroupN/AN/AN/AN/AN/APGNYProgynyN/AN/AN/AN/AN/ATALKTalkspaceN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioADUSAddus HomeCare0.171.741.74PACSPACS GroupN/AN/AN/APGNYProgynyN/A2.702.70TALKTalkspaceN/A6.516.51Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipADUSAddus HomeCare95.35%PACSPACS GroupN/APGNYProgyny94.93%TALKTalkspace57.37%Insider OwnershipCompanyInsider OwnershipADUSAddus HomeCare4.50%PACSPACS GroupN/APGNYProgyny9.40%TALKTalkspace23.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableADUSAddus HomeCare49,70318.41 million17.58 millionOptionablePACSPACS Group32,433152.40 millionN/AOptionablePGNYProgyny31085.98 million77.90 millionOptionableTALKTalkspace500167.47 million128.11 millionOptionableTALK, ADUS, PGNY, and PACS HeadlinesRecent News About These CompaniesTalkspace (TALK) Gets a Buy from William BlairAugust 22 at 7:41 AM | theglobeandmail.comSCHOOL PHONE BAN: Talkspace CEO speaks on teen mental health and offers tips for parentsAugust 21 at 12:13 AM | cbs6albany.comCTalkspace to Participate in Upcoming Investor ConferenceAugust 21 at 4:05 PM | globenewswire.comVoss Capital LP Sells 538,277 Shares of Talkspace, Inc. $TALKAugust 21 at 6:52 AM | marketbeat.comThe growth of mental health apps and teletherapy: why they’re so popularAugust 20 at 5:34 AM | miamitimesonline.comMCity-funded youth mental health therapy services are being used moreAugust 19 at 4:24 AM | seattletimes.comSDeutsche Bank AG Has $13.07 Million Stock Holdings in Talkspace, Inc. (NASDAQ:TALK)August 16, 2025 | marketbeat.comTALK | Talkspace Inc. Annual Income Statement | MarketWatchAugust 14, 2025 | marketwatch.comTalkspace adopts Express Access, AI-powered referral infrastructureAugust 12, 2025 | msn.comFY2025 EPS Estimates for Talkspace Decreased by AnalystAugust 12, 2025 | americanbankingnews.comTalkspace, Inc. (NASDAQ:TALK) is NVP Associates LLC's 2nd Largest PositionAugust 11, 2025 | marketbeat.comFY2025 EPS Estimates for Talkspace Cut by Northland CapmkAugust 11, 2025 | marketbeat.comQ3 Earnings Forecast for Talkspace Issued By Northland CapmkAugust 9, 2025 | marketbeat.comWilliam Blair Brokers Lower Earnings Estimates for TalkspaceAugust 7, 2025 | marketbeat.comEarnings To Watch: Talkspace Inc (TALK) Reports Q2 2025 ResultAugust 6, 2025 | finance.yahoo.comTalkspace to Participate in Upcoming Investor ConferenceAugust 6, 2025 | globenewswire.comTalkspace boosts AI investments, plans to build out behavioral health LLMsAugust 5, 2025 | fiercehealthcare.comFTalkspace targets 30% plus annual payer business growth as AI investments accelerate member engagementAugust 5, 2025 | msn.comTalkspace, Inc. (TALK) Q2 2025 Earnings Call TranscriptAugust 5, 2025 | seekingalpha.comTalkspace Announces Second Quarter 2025 ResultsAugust 5, 2025 | finance.yahoo.com7TALK : Talkspace's Earnings OutlookAugust 5, 2025 | benzinga.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesBuffett Makes Big Moves Outside of UNH: A Buy and Sell BreakdownBy Leo Miller | August 18, 2025Why the American Eagle Stock Rally Isn't Just Speculation By Gabriel Osorio-Mazilli | July 28, 20253 Companies That Will Profit From Trump's Semiconductor TariffsBy Jordan Chussler | August 14, 20253 Stocks Riding the AI Data Center Buildout WaveBy Chris Markoch | August 6, 20253 Materials Stocks Everyone Is Talking About Right NowBy Nathan Reiff | July 30, 2025TALK, ADUS, PGNY, and PACS Company DescriptionsAddus HomeCare NASDAQ:ADUS$118.41 +4.23 (+3.70%) Closing price 04:00 PM EasternExtended Trading$118.41 0.00 (0.00%) As of 05:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.PACS Group NYSE:PACS$12.02 +0.29 (+2.43%) Closing price 03:59 PM EasternExtended Trading$12.21 +0.20 (+1.62%) As of 06:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.Progyny NASDAQ:PGNY$23.53 +0.40 (+1.73%) Closing price 04:00 PM EasternExtended Trading$23.23 -0.30 (-1.27%) As of 05:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.Talkspace NASDAQ:TALK$2.80 +0.08 (+2.94%) Closing price 04:00 PM EasternExtended Trading$2.77 -0.03 (-1.07%) As of 07:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Talkspace, Inc. operates as a virtual behavioral healthcare company in the United States. The company offers psychotherapy and psychiatry services through its platform to individuals, enterprises, and health plans and employee assistance programs. It provides text, audio, and video-based psychotherapy from licensed therapists. The company offers Talkspace Employee Assistance Program (EAP) and Talkspace Behavioral Health plan (BH) that provides online therapy to members through BH and EAP offerings; and Talkspace for Business for members to access its platform services on a benefit plan paid by the enterprise. It serves its platform through third-party platforms or marketplace, such as Apple App Store and Google Play App Store. Talkspace, Inc. was founded in 2012 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Alphabet’s Breakout Potential: From Laggard to AI Leader After Earnings Miss, Walmart Is Still a Top Consumer Staples Play Should You Join Buffett and Invest in Constellation Brands? Can Identity Security Fuel CrowdStrike’s Next Growth Phase? 3 Robotics Stocks at the Heart of the Robotics Revolution Analog Devices and an AI-Driven Semiconductor Supercycle Shopify’s Risk-Reward Profile Is Suddenly Red Hot 3 Reasons Salesforce Is a Bargain Right Now Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.